Georgejason/iStock Editorial via Getty Images
Illumina (NASDAQ:ILMN) has been cut to underweight from equal weight by Barclays over concerns the company may be facing sanctions in China and risks to its 2025 and long-range guidance.
“Given our ratings are relative to our universe, we struggle to
